Funded Tech Companies
Biosplice Therapeutics
Wondering who provided funding to Biosplice Therapeutics? Symbiosis, Sands Capital Management and aMoon Partners invested in this biopharmaceutical company.
Company Overview
Company Name
Biosplice Therapeutics
Company Status
Private & Independent
Industry
Funding Rounds
Total Funding
Contact Information
Mailing Address
9360 Towne Centre Dr.
San Diego, CA 92121
USA
San Diego, CA 92121
USA
Phone
Website
Email Address
Company Background Information
Overview
Biosplice is developing first-in-class, small-molecule therapeutics based on pioneering science of alternative pre-mRNA splicing. Stemming from foundational discoveries in Wnt pathway modulation, Biosplice has elucidated novel biology linking CLK/DYRK kinases to the therapeutic regulation of alternative splicing.
Profile
Social Media
Company News
Facebook
YouTube
Last Transaction
4/16/2021
Financing History
Date
Type
Amount
Management Team
Title
Name
Email & Social
Chairman
Osman Kibar
Chief Executive Officer
Cevdet Samikoglu
Chief Financial Officer
Erich Horsley
Chief Medical Officer
Darrin Beaupre
Chief Medical Officer
Yusuf Yazici
Chief Operating Officer
Philippe Marchand
Chief Scientific Officer
Michael White
VP - General Counsel
Arman Oruc
Company Investors
- Symbiosis
- Sands Capital Management
- aMoon Partners (Gur Roshwalb)
- Eventide Asset Management (Joy Ghosh)
- Verition Fund Management
Browse more funded tech companies:
BioSphere Medical | BioSqueeze
Share this article
About Our Venture Capital Database
This tech company profile is powered by VentureDeal.com, a leading provider of venture capital transaction data.
Additional Resources for Entrepreneurs